Sutro Biopharma (STRO) FCF Margin (QoQ) (2018 - 2025)

Sutro Biopharma (STRO) FCF Margin (QoQ) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Sutro Biopharma 202.59 Mn 61.16 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 602.00
Sep 30, 2025 -33,918.00
Jun 30, 2025 32,016.00
Mar 31, 2025 11,047.00
Dec 31, 2024 25,028.00
Sep 30, 2024 -78,490.00
Jun 30, 2024 53,497.00
Mar 31, 2024 -51,360.00
Dec 31, 2023 19,732.00
Sep 30, 2023 13,017.00
Jun 30, 2023 17,365.00
Mar 31, 2023 -22,952.00
Dec 31, 2022 -52,888.00
Sep 30, 2022 29,130.00
Jun 30, 2022 59,122.00
Mar 31, 2022 -28,673.00
Dec 31, 2021 -3,024.00
Sep 30, 2021 -27,504.00
Jun 30, 2021 19,230.00
Mar 31, 2021 3,460.00